81 related articles for article (PubMed ID: 10727032)
1. Dehydroepiandrosterone-sulfate (DHEA-S) restores the release of IGF-I from natural killer (NK) immune in old patients with dementia of Alzheimer's type (DAT).
Solerte SB; Gornati R; Cravello L; Albertelli N; Oberti S; Perotta D; Rossi G; Cuzzoni G; Ferrari E; Fioravanti M
J Endocrinol Invest; 1999; 22(10 Suppl):32-4. PubMed ID: 10727032
[No Abstract] [Full Text] [Related]
2. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I.
Solerte SB; Fioravanti M; Vignati G; Giustina A; Cravello L; Ferrari E
J Clin Endocrinol Metab; 1999 Sep; 84(9):3260-7. PubMed ID: 10487697
[TBL] [Abstract][Full Text] [Related]
3. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
Solerte SB; Ferrari E; Cuzzoni G; Locatelli E; Giustina A; Zamboni M; Schifino N; Rondanelli M; Gazzaruso C; Fioravanti M
Dement Geriatr Cogn Disord; 2005; 19(1):1-10. PubMed ID: 15383738
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects.
Bo M; Massaia M; Zannella P; Cappa G; Ferrario E; Rainero I; Arvat E; Giordano R; Molaschi M
Int J Geriatr Psychiatry; 2006 Nov; 21(11):1065-70. PubMed ID: 16977674
[TBL] [Abstract][Full Text] [Related]
5. Impairment of secretory pattern of IGF-I from lymphomononuclear cells in aging and dementia of the Alzheimer's and vascular type.
Solerte SB; Cerutti N; Mirani M; Ceresini G; Giusti A; Ferrari E; Fioravanti M
J Endocrinol Invest; 2002; 25(10 Suppl):47-50. PubMed ID: 12508915
[No Abstract] [Full Text] [Related]
6. DHEA(S): the fountain of youth.
Leowattana W
J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S605-12. PubMed ID: 11853289
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?
Carro E; Torres-Aleman I
Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618
[TBL] [Abstract][Full Text] [Related]
8. Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): implications in the pathogenesis of Alzheimer's disease.
Sinha M; Saha A; Basu S; Pal K; Chakrabarti S
Neurosci Lett; 2010 Oct; 483(2):123-6. PubMed ID: 20691758
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type.
Solerte SB; Fioravanti M; Schifino N; Cuzzoni G; Fontana I; Vignati G; Govoni S; Ferrari E
Dement Geriatr Cogn Disord; 1999; 10(1):21-7. PubMed ID: 9844034
[TBL] [Abstract][Full Text] [Related]
10. The nutritional status has no major role in the age-related reduction of IGF-I secretion.
Baffoni C; Benso A; Broglio F; Tassone F; Bellone S; Corneli G; Rovere S; Origlia C; Aimaretti G
J Endocrinol Invest; 2002; 25(10 Suppl):53-4. PubMed ID: 12508917
[No Abstract] [Full Text] [Related]
11. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.
Yen SS
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8167-9. PubMed ID: 11459947
[No Abstract] [Full Text] [Related]
12. [Dehydroepiandrosterone (DHEA)--youth hormone?].
Zdrojewicz Z; Kesik S
Wiad Lek; 2001; 54(11-12):693-704. PubMed ID: 11928558
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone sulfate and growth axis hormones in patients after surgery.
Osorio A; Vara-Thorbeck R; Rosell J; Osorio C; Ortega E; Ruiz-Requena E
World J Surg; 2002 Sep; 26(9):1079-82. PubMed ID: 12181608
[TBL] [Abstract][Full Text] [Related]
14. [Neuropsychic effects of dehydroepiandrosterone].
Rigaud AS; Pellerin J
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS43-9. PubMed ID: 11435994
[TBL] [Abstract][Full Text] [Related]
15. The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease.
Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Mersich N; Huber ER; Geyer G; Tragl KH
Exp Gerontol; 2005 Mar; 40(3):157-63. PubMed ID: 15763392
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
Carro E; Trejo JL; Spuch C; Bohl D; Heard JM; Torres-Aleman I
Neurobiol Aging; 2006 Nov; 27(11):1618-31. PubMed ID: 16274856
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
18. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS.
Maes M; Mihaylova I; De Ruyter M
Neuro Endocrinol Lett; 2005 Oct; 26(5):487-92. PubMed ID: 16264414
[TBL] [Abstract][Full Text] [Related]
19. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A
Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955
[TBL] [Abstract][Full Text] [Related]
20. The correlations between endogenous dehydroepiandrosterone sulfate and some atherosclerosis risk factors in premenopausal women.
Bednarek-Tupikowska G; Tworowska-Bardzińska U; Tupikowski K; Bohdanowicz-Pawlak A; Szymczak J; Kubicka E; Skoczyńska A; Milewicz A
Med Sci Monit; 2008 Jan; 14(1):CR37-41. PubMed ID: 18160943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
